Madrid, 30 July 2026. Nazca Capital, a leading private equity firm focused on investing in Spanish lower mid-market companies, has acquired a majority stake in Aldous Bio through its Nazca Small Cap II fund. Aldous is Spain leading digital-native brand of science-backed food supplements.
Founded in 2018 in Almonacid del Marquesado (Cuenca), Aldous has established itself as Spain best-selling food supplements brand on both Amazon and TikTok, while also becoming the first digital-native company in the sector to successfully expand into physical retail.
Today, its products are available through retailers including Druni, El Corte Inglés, Herbolario Navarro and Costco, further reinforcing its successful omnichannel strategy. Aldous has also reached more than three million customers who incorporate its products into their annual wellness routines, strengthening its position as one of the leading players in the Spanish supplements market.
The company has developed a broad portfolio of more than 80 products, recognised for their quality, functionality and the strong scientific evidence underpinning their ingredients. Innovation remains at the core of its strategy, reflected both in the continuous development of new products and the launch of entirely new ranges, including powdered supplements and ready-to-drink liquid single-dose formats.
This innovation capability is complemented by a differentiated sustainability proposition based on larger product formats that reduce transport-related emissions, plastic-free packaging and a strong commitment to creating employment opportunities in rural communities.
This positioning has enabled the company to deliver significant growth, with revenue expected to exceed €40 million this year, more than doubling 2025 sales.
Nazca investment supports an ambitious growth plan aimed at reaching €100 million in annual revenue by strengthening the brand across its existing sales channels, continuing to expand its product offering and accelerating international growth.
The plan also includes the construction of a new production facility, which will create a significant number of jobs in Almonacid del Marquesado (Cuenca), reinforcing Aldous Bio long-standing commitment to generating employment in the village where it was founded, which has fewer than 500 inhabitants.
Nazca will bring to Aldous its extensive sector expertise, having already completed four successful investments in the nutraceutical industry. Antonio Pellón, founder and CEO of Aldous, will retain a significant shareholding and continue to lead the business. The transaction also marks the exit of KM ZERO Food Innovation Hub, which has supported the company since 2020.
Antonio Pellón, Founder and CEO of Aldous, commented:
“Nazca investment represents a major step towards building a leading European brand while preserving the essence of Aldous Bio and our commitment to creating employment in Cuenca. We are convinced that Nazca is the right partner for this next stage of growth, bringing extensive sector expertise while sharing our vision, ambition and way of working. We would also like to thank KM ZERO for the journey we have shared together. Without their support, Aldous would not have become the leading food supplements brand in the Spanish market.”
Celia Pérez-Beato, Chief Executive Officer of Nazca, added:
“Aldous is a perfect fit with our investment strategy: a company founded and led by a first-class entrepreneur, with a differentiated value proposition and significant potential to become a leading pan-European brand. We have strong conviction in the long-term growth of the nutraceutical sector, where our successful track record and industry expertise can help accelerate Aldous next stage of development.”
As part of the transaction, Nazca was advised by Sabadell, PwC, Pérez-Llorca and Global Factor, while Aldous was advised by Albia IMAP and Gómez-Acebo & Pombo.